MAIN ALAN J 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
MAIN ALAN J
EVP, Pharmaceutical Research
Transactions
- Exercise/Conversion
Common Stock
2023-02-28+23,300→ 198,889 total - Exercise/Conversion
Common Stock
2023-02-28+8,976→ 207,865 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−23,300→ 0 total→ Common Stock (23,300 underlying) - Exercise/Conversion
Restricted Stock Units
2023-02-28−8,976→ 8,977 total→ Common Stock (8,976 underlying) - Exercise/Conversion
Common Stock
2023-02-28+25,667→ 233,532 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−25,667→ 51,333 total→ Common Stock (25,667 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−20,946$45,453→ 212,586 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.